We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-1.51%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$682B
AUM Growth
-$35.2B
Cap. Flow
-$15.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
31.41%
Holding
2,959
New
69
Increased
1,665
Reduced
971
Closed
71

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$2.48B
2
KVUE icon
Kenvue
KVUE
+$1.5B
3
HAL icon
Halliburton
HAL
+$1.12B
4
BA icon
Boeing
BA
+$950M
5
SCHW
Charles Schwab
SCHW
+$920M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.64B
2
AAPL icon
Apple
AAPL
+$1.9B
3
AMD icon
Advanced Micro Devices
AMD
+$1.66B
4
JNJ icon
Johnson & Johnson
JNJ
+$1.56B
5
AMZN icon
Amazon
AMZN
+$1.17B

Sector Composition

Rank Sector Weight
1 Technology 29.76%
2 Healthcare 16.83%
3 Financials 10.91%
4 Consumer Discretionary 10.77%
5 Communication Services 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GORO icon
2801
Goldgroup Mining Inc.
GORO
$211M
$37K ﹤0.01%
84,700
ORGN
2802
DELISTED
Origin Materials
ORGN
$37K ﹤0.01%
952
+223
+31% +$17.5K
DRRX
2803
DELISTED
DURECT Corp
DRRX
$36K ﹤0.01%
14,210
EFA icon
2804
iShares MSCI EAFE ETF
EFA
$80.2B
$36K ﹤0.01%
+510
New +$36.5K
ERAS icon
2805
Erasca
ERAS
$6.5B
$35K ﹤0.01%
17,681
+2,224
+14% +$5.7K
ESPR
2806
DELISTED
Esperion Therapeutics
ESPR
$35K ﹤0.01%
35,400
+19,800
+127% +$28.6K
SLQT icon
2807
SelectQuote
SLQT
$124M
$35K ﹤0.01%
29,488
+3,088
+12% +$4.66K
EMKR
2808
DELISTED
Emcore Corp
EMKR
$35K ﹤0.01%
7,160
SRTA
2809
Strata Critical Medical Inc
SRTA
$533M
$34K ﹤0.01%
12,847
+1,280
+11% +$4.5K
BNGO icon
2810
Bionano Genomics
BNGO
$13.8M
$34K ﹤0.01%
183
+88
+93% +$23.1K
BTBT icon
2811
Bit Digital
BTBT
$509M
$34K ﹤0.01%
15,469
+791
+5% +$2.48K
CVM icon
2812
CEL-SCI Corp
CVM
$25.9M
$34K ﹤0.01%
893
NAUT icon
2813
Nautilus Biotechnolgy
NAUT
$114M
$34K ﹤0.01%
10,450
+438
+4% +$1.43K
PHLT
2814
DELISTED
Performant Healthcare Inc
PHLT
$34K ﹤0.01%
14,681
+1,012
+7% +$2.57K
LIDR icon
2815
AEye
LIDR
$61.4M
$33K ﹤0.01%
5,097
+2,664
+109% +$21.4K
PSTX
2816
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$33K ﹤0.01%
13,831
DC icon
2817
Dakota Gold
DC
$841M
$32K ﹤0.01%
+12,125
New +$34.5K
KULR icon
2818
KULR Technology Group
KULR
$137M
$32K ﹤0.01%
10,975
WWR icon
2819
Westwater Resources
WWR
$81M
$31K ﹤0.01%
45,000
BKSY icon
2820
BlackSky Technology
BKSY
$1.3B
$30K ﹤0.01%
3,203
+200
+7% +$2.54K
KLTR icon
2821
Kaltura
KLTR
$241M
$30K ﹤0.01%
16,888
STTK icon
2822
Shattuck Labs
STTK
$752M
$30K ﹤0.01%
19,300
XFOR icon
2823
X4 Pharmaceuticals
XFOR
$425M
$30K ﹤0.01%
893
+59
+7% +$2.57K
VLD
2824
DELISTED
Velo3D, Inc.
VLD
$30K ﹤0.01%
534
NOTE
2825
DELISTED
FiscalNote
NOTE
$29K ﹤0.01%
1,133
+78
+7% +$2.67K

Similar funds

T. Rowe Price Associates's Q3 2023 Portfolio in Review

As of Q3 2023, T. Rowe Price Associates held 2,959 positions worth $682B, down 4.9% from $718B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.7%. T. Rowe Price Associates opened 69 new positions and exited 71, leaving the 2,959-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q3 2023 buy was Maplebear: 6,435,942 shares worth $191M.
  • T. Rowe Price Associates added most to SLB Ltd in Q3 2023, an estimated $2.48B increase.
  • T. Rowe Price Associates's biggest Q3 2023 reduction was Microsoft, cutting an estimated $2.64B.
  • T. Rowe Price Associates fully exited Life Storage, Inc. in Q3 2023, selling an estimated $285M.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $682B portfolio in Q3 2023.
  • T. Rowe Price Associates opened 69 new positions and closed 71 in Q3 2023.
  • T. Rowe Price Associates's portfolio value fell 4.9% quarter-over-quarter to $682B.

Based on T. Rowe Price Associates's 13F filing for Q3 2023, filed 14 Nov 2023.